Identification of new selective CD36 inhibitors to potentiate HER2-targeted therapy in HER2-positive breast cancer

L Lorenzo Castagnoli F Francesco Bonì M Martina Bigliardi P Paolo Toneguzzo P Paola A. Corsetto G Giorgia Galasso A Alma Franceschini P Paolo Cocomazzi V Viola Regondi C Cristian Capuzzoni A Angela M. Rizzo F Francesca Ligorio C Claudio Vernieri P Pierfausto Seneci D Daniela Arosio E Elda Tagliabue E Eloise Mastrangelo M Mario Milani S Serenella M. Pupa

Article Details

Volume / Issue Vol. 15, Issue 1
Published August 06, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (19)

L

Lorenzo Castagnoli

F

Francesco Bonì

M

Martina Bigliardi

P

Paolo Toneguzzo

P

Paola A. Corsetto

G

Giorgia Galasso

A

Alma Franceschini

P

Paolo Cocomazzi

V

Viola Regondi

C

Cristian Capuzzoni

A

Angela M. Rizzo

F

Francesca Ligorio

C

Claudio Vernieri

P

Pierfausto Seneci

D

Daniela Arosio

E

Elda Tagliabue

E

Eloise Mastrangelo

M

Mario Milani

S

Serenella M. Pupa